Showing results (211-220 of 499) with videos related to

Sort By:
Pageof 50
Biochimica Et Biophysica Acta|April 13, 2005
Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41Shuwen Liu, Hong Lu, Qian Zhao, et al.
Science Bulletin|June 28, 2024
Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variantsHao Zhou, Ping Leng, Yang Wang, et al.
Chemmedchem|June 21, 2011
An amphiphilic conjugate approach toward the design and synthesis of betulinic acid-polyphenol conjugates as inhibitors of the HIV-1 gp41 fusion core formationYan Liu, Zhuofeng Ke, Kwok Yiu Wu, et al.
Journal of Virology|September 5, 2008
Conserved salt bridge between the N- and C-terminal heptad repeat regions of the human immunodeficiency virus type 1 gp41 core structure is critical for virus entry and inhibitionYuxian He, Shuwen Liu, Jingjing Li, et al.
Viruses|November 6, 2019
Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus InhibitorsYaning Gao, Wanbo Tai, Ning Wang, et al.
Biochemical and Biophysical Research Communications|August 7, 2008
Novel anti-HIV peptides containing multiple copies of artificially designed heptad repeat motifsWeiguo Shi, Zhi Qi, Chungen Pan, et al.
Antimicrobial Agents and Chemotherapy|February 8, 2017
Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike ParticlesHaoyang Li, Fei Yu, Shuai Xia, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Synthesis and anti-HIV-1 activity of 4-[4-(4,6-bisphenylamino-triazin-2-ylamino)-5-methoxy-2-methylphenylazo]-5-hydroxynaphthalene-2,7-disulfonic acid and its derivativesKannan P Naicker, Shibo Jiang, Hong Lu, et al.
Bioorganic & Medicinal Chemistry|January 30, 2008
Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitorsCátia Teixeira, Florent Barbault, Joseph Rebehmed, et al.
Virus Research|December 3, 2014
Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike proteinShuai Xia, Qi Liu, Qian Wang, et al.
Pageof 50